InsiderClue
Insiders · Profile

King Michael

CHIEF FINANCIAL OFFICER at SAB Biotherapeutics. Filing since 30 Nov 2023. CIK 0001998530

Company
Date
Role
Action
Shares
Amount
Of holding
SABS SAB Biotherapeutics, Inc.
30 Nov 2023
CHIEF FINANCIAL OFFICER
Bought
5,000
$4.50K
opened
1 decision on file.